N-acetilcysteine prevents the <i>A</i>. <i>simplex</i> CE-induced TEER decrease. by Noelia Carballeda-Sangiao (2889611)

JNJ26993135 + BML-111 decreases permeability and enhances ZO-1 and claudin-1 induced by PAF but does not change TEER. by Kameljit K. Kalsi (16496511)

Transepithelial electrical resistance (TEER) (N = 6). by Shirko Marcel Shokr (19173337)

“…<p><b>(A)</b> During the cultivation of SMC and ALI we observed significantly differences on day 18 (SMC: 9.61 kΩ*cm²; ALI: 7.73 kΩ*cm²; p<0.05) and day 25 (SMC: 8.19 kΩ*cm²; ALI: 6.44 kΩ*cm²; p<0.05) ALI cultures showed significantly decreased values compared to SMC. …”

Characterization of the study population based on depressive symptoms. by Shuning Li (3843793)

Bivariate logistic regression for factors having significant association with anxiety and depression. by Dilasha K. C. (19251192)

Subjects:

Class status with most significant 11 input features. by Umme Marzia Haque (11846815)

Differential treatment effects and clinically significant changes in stress, anxiety and depression (DASS). by Brendan Cullen (7003883)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

Significant major depression candidate risk genes for three gene-based methods (MAGMA, eMAGMA, S-PrediXcan). by Zachary F. Gerring (6954416)

“…<p>Significant major depression candidate risk genes for three gene-based methods (MAGMA, eMAGMA, S-PrediXcan).…”

Number of trials with significant or non-significant outcomes by intervention and period of final assessment for depression, posttraumatic stress and functional impairment. by Ruta Rangel (22662812)

Forest plot of sex-based differences for depression. by Liang-Tseng Kuo (4861600)

Depression assessed with: Beck Depression Inventory (BDI-II). by Andrea Scerbe (15572740)

Subjects:

Selected behavioral, psychological and clinical outcomes based on tests of significance between the Intervention and control group. by Kalayou Kidanu Berhe (9557751)

Overlap in the number of significant gene-level associations between MAGMA, eMAGMA, and S-PrediXcan. by Zachary F. Gerring (6954416)

Spiritual Well-being and its dimensions based on anxiety and depression (n = 200). by Mohsen Vakili Sadeghi (21567467)

Depression assessed with: Center for Epidemiological Studies Depression Scale (CES-D). by Andrea Scerbe (15572740)

Subjects:

Prevalence of depression among nurses based on DASS-21. by Emmanuel Dapilah (20324135)

Subjects:

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

Differential treatment effects and clinically significant change in depression (IDS) for all three treatments over time. by Brendan Cullen (7003883)

Means in primary anxiety, depressive and somatic symptom disorders subsamples and effect sizes in anxious and depressive subsample. by Carmen Schaeuffele (13028906)